Document:

DISTRIBUTION AGREEMENT

 Exhibit 10.24 
 ABIOMED, INC. 
 DISTRIBUTION AGREEMENT 
 This Distribution Agreement (“Agreement”) is entered into as of November 4, 2006, by and between ABIOMED, Inc., a Danvers, Massachusetts, USA-based
Corporation with principal offices at 22 Cherry Hill Drive (“Manufacturer”), and MEDIX Japan, Inc., a Koga City, Fukuoka, Japan-based company with principal offices at 361-1 Aoyagimachi (“Medix”) (“Distributor”).

 RECITALS 
 Manufacturer is in the business of
producing cardiac support devices designed to assist or replace the pumping function of the failing heart. The Distributor will obtain all necessary approvals, licenses and reimbursement authorization for the sale and marketing and distribution of
Manufacturer’s products in the geographical area of Japan (the “Territory”) on the terms and conditions set forth in this agreement. 
 AGREEMENT 
 In consideration of the mutual representations, warranties, covenants and promises contained herein, Manufacturer and Distributor each
agree as follows: 
  

	 	1.	DEFINITIONS 

  

	 	a)	“Products” shall mean those products listed in Exhibit A attached hereto. Products may be updated, discontinued or added by Manufacturer, at its sole discretion, provided
that Manufacturer gives at least six (6) months prior written notice to Distributor (except in the event of any restrictions on product imposed by regulatory authorities for which Manufacturer will endeavor to provide prior notice but cannot
commit to always being able to provide such notice). A product is “discontinued” only if Manufacturer no longer manufactures the Product for sale or distribution in the Territory. 

  

	 	b)	“Territory” shall mean that geographic area identified in Exhibit B attached hereto. 

  

	 	2.	APPOINTMENT AND AUTHORITY OF DISTRIBUTOR 

  

	 	a)	Appointment. Subject to the terms and conditions set forth herein, Manufacturer hereby appoints Distributor as Manufacturer’s sole and exclusive Distributor for the
Products in the Territory, and Distributor hereby accept such appointment. During the term of this Agreement, Manufacturer shall not appoint any other distributor, agent or representative to sell the Products to customers in the Territory without
the express permission of the Distributor, and shall not itself sell the Products to customers in the Territory. 

  

	 	b)	Territorial Responsibility. Distributor shall actively pursue sales opportunities and prospects to realize the maximum sales potential for the Products in the Territory.

  

	 	c)	 Conflict of Interest. Distributor warrants to Manufacturer that it does not currently represent or promote any lines or products that compete with the
Products. During the term of this Agreement, Distributor, including its employees, officers, directors and affiliated companies, 

  

 Page 1 

	 	 
shall not, without Manufacturer’s prior written consent, represent, promote or otherwise try to sell within the Territory any lines or products that are
reasonably perceived to compete with the Products covered by this Agreement. Immediately prior to the execution of this Agreement, Distributor shall provide Manufacturer with a list of the companies and products that it currently represents and
shall notify Manufacturer in writing of any new companies and products at such time as its promotion of those new companies and products commences. 

  

	 	d)	Importer. Importer shall mean the party that, once all necessary approvals and licenses are obtained from the appropriate Ministries, holds the Shonin and is primarily
responsible for maintaining and complying with all such approvals and licenses. For purposes of this Agreement, Importer is understood to be Distributor. 

  

	 	e)	Independent Contractors. The relationship between Manufacturer and Distributor established by this Agreement is that of independent contractors, and nothing contained in this
Agreement shall be construed to (i) give Manufacturer or Distributor the power to direct and control the day-to-day activities of the other, (ii) constitute the parties as partners, joint venturers, co-owners or otherwise as participants
in a joint or common undertaking, or (iii) allow Distributor to create or assume any obligation on behalf of Manufacturer for any purpose whatsoever. 

 All financial obligations associated with Distributor’s business are the sole responsibility of Distributor. All sales and other agreements between Distributor and its customers are Distributor’s exclusive
responsibility and shall have no effect on Distributor’s obligations under this Agreement. Distributor shall be solely responsible for, and shall indemnify and hold Manufacturer free and harmless from, any and all claims, damages or lawsuits
(including Manufacturer’s attorneys’ fees) arising out of the acts of Distributor, its employees, its directors and its agents. 
  

	 	3.	TERMS OF PURCHASE OF PRODUCTS BY DISTRIBUTOR 

  

	 	a)	Terms and Conditions. All purchases of Products by Distributor from Manufacturer during the term of this Agreement shall be subject to the terms and conditions of this
Agreement. The terms and conditions of this Agreement, including Distributor’s minimum purchase commitments and Distributor’s other obligations to Manufacturer under this Agreement, will not be modified by any such agreement which might
separately be reached between Distributor and any third party unless specifically agreed to in writing by Manufacturer. 

  

	 	b)	Prices. All prices are F.O.B. Manufacturer’s plant, currently located at the address(es) listed for Manufacturer in Exhibit C. The purchase price to Distributor for each
of the Products (“Purchase Price”) shall be as set forth in Exhibit A, attached hereto. The difference between Distributor’s Purchase Price and Distributor’s selling price to its customers shall be Distributor’s sole
remuneration for sale of the Products and for all other obligations of the Distributor under this Agreement. Manufacturer has the right at any time to revise the prices in Exhibit A with ninety (90) days’ advance written notice to the
Distributor. Such revisions shall apply to all orders received by Manufacturer after the effective date of the revision. Price increases shall not affect unfulfilled purchase orders accepted by Manufacturer prior to the effective date of the price
increase. 

  

 Page 2 

	 	c)	Taxes. Distributor’s Purchase Price does not include any federal, state or local taxes that may be applicable to the Products in the Territory or otherwise. Manufacturer
shall not be responsible for any taxes on the sale of the Products by Distributor to Distributor’s customers. Pricing per this Agreement represents the net cash amount to be received by Manufacturer. If Manufacturer has an obligation to
collect, remit or have withheld any such taxes, duties or fees, an amount shall be added to Distributor invoice and paid by Distributor such that the net amount of cash received by Manufacturer equals the pricing per this Agreement.

  

	 	d)	Order and Acceptance. All orders for Products submitted by Distributor shall be initiated by purchase orders sent to Manufacturer and requesting a delivery date during the
term of this Agreement. Delivery of an order shall be considered complete when received by Manufacturer via regular mail, commercial carrier or facsimile or email; provided, however, that an order may initially be placed orally. Manufacturer shall
use its reasonable best efforts to notify Distributor of the acceptance or rejection of an order and of the assigned delivery date within thirty (30) days after receipt of the purchase order. Manufacturer shall use its reasonable best efforts
to deliver Products at the times specified either in its quotation or in its written acceptance of Distributor’s purchase orders. 

  

	 	e)	Terms of Purchase Orders. Distributor’s purchase orders submitted to Manufacturer from time to time, with respect to Products to be purchased hereunder, shall be
governed by the terms of this Agreement, and nothing contained in any such purchase order shall in any way modify such terms of purchase or add any additional terms or conditions. 

  

	 	f)	Change Orders. Distributor may utilize written change orders without penalty for orders that have not yet been accepted by Manufacturer. For orders that have been accepted by
Manufacturer, but have not yet been shipped, Distributor may utilize written change orders subject to the following conditions: 

  

	 	i)	Distributor may delay delivery of any accepted order, provided that the rescheduled delivery date occurs during the term of this Agreement and provided further that Distributor
shall pay a rescheduling fee equal to ten percent (10%) of the Purchase Price (net of freight, taxes, and other charges) of the rescheduled Products if Distributor’s change order is received by Manufacturer less than ninety (90) days
before the assigned delivery date. 

  

	 	    	Unless Manufacturer otherwise agrees, no change order shall be effective unless accompanied by the rescheduling fee, if any, required by this Subsection 3(f)(i).

  

	 	ii)	Distributor may cancel any order that has been accepted by Manufacturer, provided that if the written change order is received by Manufacturer no less than ninety (90) days
before the assigned delivery date or if the written change order cancels an order that has been previously rescheduled under Subsection 3 (f) (i) above, then Distributor shall pay a cancellation charge equal to fifteen percent
(15%) of the net Purchase Price of the canceled Products. 

  

 Page 3 

	 	iii)	Distributor MAY NOT cancel any order once Manufacturer has initiated manufacturing, to the extent such manufacturing has been initiated to fulfill such order.

  

	 	g)	Payment. Full payment of Distributor’s Purchase Price for the Products and spare parts (including any freight, taxes or other applicable costs initially paid by
Manufacturer but to be borne by Distributor) shall be made by Distributor to Manufacturer in US Dollars within sixty (60) days after delivery of the Products to a carrier. Manufacturer may elect, at its sole discretion, to receive payment by
letter of credit made by a bank acceptable to Manufacturer or by a wire transfer made as directed by Manufacturer. All exchange, interest, banking, collection, and other charges shall be at Distributor’ expense. Any invoiced amount not paid
when due shall be subject to a service charge of one-half percent (0.5%) per month. 

  

	 	h)	Shipping. All Products delivered pursuant to the terms of this Agreement shall be suitably packed for shipment in Manufacturer’s standard shipping cartons or containers,
marked for shipment to Distributor’s address set forth above unless otherwise specified, and delivered to Distributor or its carrier agent F.O.B. Manufacturer’s manufacturing plant, at which time (subject to Subsection 3(k) below) title to
such Products and risk of loss shall pass to Distributor. Manufacturer shall select the carrier. All freight, insurance, and other shipping expenses, as well as any special packing expense, shall be paid by Distributor. Distributor shall also bear
all applicable taxes, duties and similar charges that may be assessed against the Products after delivery to the carrier at Manufacturer’s plant. 

  

	 	i)	Rejection of Products. Distributor shall inspect all Products promptly upon receipt thereof and may reject any Product that fails in any material way to meet the
specifications set forth in Manufacturer’s current published specifications for that Product. Any Product not properly rejected within thirty (30) days after receipt of that Product by Distributor (“Rejection Period”) shall be
deemed accepted. Sterile Products must be accepted or rejected within 30 days after shipment to customer from Distributor’s warehouses, but in no event later than its sterile expiration date. The sterile expiration date of a sterile Product
shall not be earlier than 5 months from the end of the labeled shelf life of the Product and in any event no less than 13 months from Distributor’s receipt of said sterile Product. To reject a Product, Distributor shall, within the Rejection
Period, notify Manufacturer in writing of its rejection and request a Return Goods Authorization (“RGA”) number. Manufacturer shall use its best efforts to provide the RGA number in writing to Distributor within fifteen (15) days
after receipt of the Distributor’s request. Within ten (10) days after receipt of the RGA number, Distributor shall return to Manufacturer the rejected Product, freight prepaid, in its original shipping carton or container with the RGA
number clearly displayed on the outside of the carton or container. Provided that Manufacturer has complied with its obligations in this Subsection 3(i), Manufacturer reserves the right to refuse to accept any rejected Product that does not bear an
RGA number clearly displayed on the outside of the carton. As promptly as possible, but no later than thirty (30) working days after receipt by Manufacturer of properly rejected Products, Manufacturer shall, at its option and expense, either
repair or replace the Products. Manufacturer shall pay, or reimburse, all reasonable shipping charges for properly rejected Products; otherwise, Distributor shall be responsible for the shipping charges. Delivery via commercial carrier, the post
office or facsimile (“FAX”) shall be considered acceptable means of written notification for the above purposes. 

  

 Page 4 

	 	j)	Return of Products After Rejection Period. After the Rejection Period, Distributor may not return a product to Manufacturer for any reason without Manufacturer’s prior
written consent. For any Product for which Manufacturer gives such consent, Manufacturer shall charge Distributor a restocking fee equal to fifteen percent (15%) of Distributor’ Purchase Price for that Product and in such case shall credit
the balance of the Purchase Price to Distributor account. Distributor shall be responsible for all shipping charges. 

  

	 	k)	Reservation of Title. Transfer of title for each Product shall occur at time of purchase. Distributor shall be responsible for all shipping charges. 

 

	 	l)	No Sales Outside of Territory. Resale of Products by Distributor outside designated Territory is prohibited. Any such activity is grounds for immediate termination of this
Agreement by Manufacturer for cause. 

  

	 	4.	TRAINING. INSTALLATION. AND SERVICE 

  

	 	a)	Services by Distributor. Distributor shall have the responsibility to install the Products, test the installed Products, service and repair the Products, and train the
customers with respect to the Products sold. The services shall be performed only by specially and properly trained personnel of Distributor and shall be prompt and of the highest quality. Distributor shall maintain a properly equipped service
department as required and shall keep on hand, at all times, accessories and equipment sufficient to meet the needs of the Territory, as well as a complete and adequate supply of spare parts to properly service Products used in the Territory (in
accordance with Subsection 6(d) below). 

  

	 	b)	Training by Manufacturer. Manufacturer shall provide reasonable sales, service, and repair training to Distributor’s personnel at periodic intervals, with the frequency
and content of the training to be determined by Manufacturer. When possible, such training shall be given at a central geographic location or at Manufacturer’s facilities. In either case, Manufacturer and Distributor shall each pay their own
costs for travel, food, and lodging during the training period. In addition to sales and service training, Manufacturer shall cooperate with Distributor in establishing efficient service procedures and policies. 

  

	 	5.	WARRANTY TO DISTRIBUTOR 

  

	 	a)	Standard Limited Warranty. Manufacturer warrants to Distributor that the Products sold to Distributor shall conform to Manufacturer’s published specifications and be
free from material defect for a period of one year from the date of delivery for non-sterile Product, and for sterile Product, for a period equal to the longer of (1) the labeled shelf life of the sterile Product less 5 months or (2) 13
months from Distributor’s receipt of said sterile Product, subject to the limitations set forth in Subsections 5(b), 5(c) and 5(d) below. This warranty is contingent upon proper use of a Product in the application for which it was intended and
does not cover Products that were modified without Manufacturer’s approval or that were subjected by the customer or by the Distributor to unusual physical or electrical stress. 

  

 Page 5 

	 	b)	No Other Warranty. Except for the express warranty set forth above, Manufacturer grants no other warranties, explicit or implied, by statute or otherwise, regarding the
Products, their fitness for any purpose, their quality, their merchantability, or otherwise. 

  

	 	c)	Limitation of Liability. Manufacturer’s liability under the warranty shall be limited to a refund of the Distributor’s purchase price. In no event shall
Manufacturer be liable to Distributor for the cost of procurement of substitute goods by the Distributor or for any special, consequential or incidental damages for breach of warranty. 

  

	 	d)	Single-Use Product Limit. Manufacturer’s warranty with respect to single use, disposable Products shall be limited to a single use only. 

  

	 	6.	ADDITIONAL OBLIGATIONS OF DISTRIBUTOR 

  

	 	a)	Purchase Commitment. Attached hereto as Exhibit D is the minimum purchase commitment (i.e., quota) for Products to be purchased by Distributor from Manufacturer. Distributor
agrees to the Minimum Purchase Requirement, as detailed in Exhibit D. Throughout the term of this Agreement, if Distributor fails to purchase its Minimum Purchase Requirement, then Manufacturer may terminate this Agreement for cause in accordance
with Section 8 below. Manufacturer’s sole remedy for Distributor’s failure to purchase its Minimum Purchase Requirement is the termination of this Agreement. Products returned to Manufacturer under the provisions of Subsection 3(i)
above shall not count towards the fulfillment of Distributor’s Minimum Purchase Requirement. 

  

	 	b)	Promotion of the Products. Distributor agrees to use its best efforts, at its own expense, to vigorously promote the sale of the Products within the Territory and to develop
a market for the Products and to enhance Manufacturer’s image in the marketplace as a provider of quality medical devices. Distributor’s obligations shall include, but not be limited to, preparing promotional materials in appropriate
languages for the Territory, advertising the Products in trade publications within the Territory, participating in appropriate trade shows, and directly soliciting orders from customers for the Product. At the beginning of this Agreement and the
beginning of each calendar year, Distributor and Manufacturer shall mutually agree in writing on the sales promotion activities and performance criteria to be met by Distributor for that calendar year. Distributor shall provide Manufacturer with an
annual analysis of the total market and realizable market for the Products in the Territory. Such information shall be provided to enable Manufacturer to assist Distributor in fully developing the market demand for the Products and in developing
appropriate marketing and business plans for the mutual advantage of Distributor and Manufacturer. 

 Distributor shall
discourage and do nothing to promote the clinical reuse of any Product intended by Manufacturer to be limited to a single patient use (i.e., a Disposable Product). In particular, Distributor agrees not to promote the reuse of any disposable Product
which has not been clinically tested, licensed and approved as “reusable” or “resterilizable”. 
 Distributor shall also
be responsible for customer education, training and technical support. 
  

 Page 6 

	 	c)	Representations. Distributor shall not make any false or misleading representations to customers or others regarding Manufacturer or Products. Distributor shall not make any
representations, warranties or guarantees with respect to the specifications, features or capabilities of the Products that are not consistent with Manufacturer’s documentation accompanying the Products or Manufacturer’s literature
describing the Products, including the limited warranty and disclaimers. Distributor shall not make any commitment on behalf of Manufacturer except as specifically defined in this Agreement or in writing from an authorized Manufacturer’s
representative. 

  

	 	d)	Inventory. Distributor shall, at its own expense, maintain a sufficient inventory of the Products and of spare parts to fulfill its commitments under this Agreement.

  

	 	e)	Finances and Personnel. Distributor shall maintain a net worth and working capital reasonably sufficient to allow Distributor to perform fully and faithfully its obligations
under this Agreement. Distributor shall devote sufficient financial resources and technically qualified sales and service engineers to the Products to fulfill its responsibilities under this Agreement. Distributor additionally agrees to maintain
qualified sales, clinical and technical personnel for the purpose of promoting and servicing the Products and agrees to provide adequate training to physicians and laboratory personnel to assist them in the proper use and maintenance of the
Products. 

  

	 	f)	Customer and Sales Reporting. Distributor shall, at its own expense and consistent with the sales policies of Manufacturer: 

 i) place the Products in Distributor’s catalogues as soon as possible and feature the Products in any applicable trade show that it attends;

 ii) provide adequate contact with existing and potential customers within the Territory on a regular basis, consistent with good business
practice and inform Manufacturer of the names of existing customers; 
 iii) assist Manufacturer in assessing customer requirements for the
Products, including modifications and improvements thereto, in terms of quality, design, functional capability, and other features; 
 iv)
submit market research information, as reasonably requested by Manufacturer, regarding competition and changes in the market within the Territory; 
 v) keep records on all Manufacturer console technology including location, order information, services performed and any pertinent customer correspondence for an indefinite period of time, and make said records available for review by
Manufacturer personnel or Manufacturer-designated individuals upon request; “console technology” includes BVS 5000, AB 5000, IMPELLA, and any new non-disposable technology that is introduced into Manufacturer’s line of products;

 vi) provide Manufacturer with any clinical data gathered for Products during the investigational stage for government approval; and

  

 Page 7 

 vii) keep records on all Manufacturer disposable products including location, order information,
expiration details and any pertinent customer correspondence for a period of three (3) years from date of product shipment, and make said records available for review by Manufacturer personnel or Manufacturer-designated individuals upon
request; “disposable products” includes BVS Blood Pump Sets, Cannula, AB Ventricles, IMPELLA RECOVER LP 2.5 Pump, IMPELLA RECOVER LP 5.0 Pump, and any new disposable technology that is introduced into Manufacturer’s line of products.

  

	 	g)	Import and Export Requirements. Distributor shall, at its own expense, secure any and all required licenses and approvals by any government other than the United States of
America and all required private and public health registrations and reimbursement for the implementation, execution and performance of the Agreement. 

 In particular, this includes responsibility for conducting, coordinating of and completing any necessary Homologation trial (CHIKEN) and includes all necessary and legal physician compensation and collaboration
related thereto. In addition, this includes but is not limited to payment of all import and export licenses and permits, customs charges and duty fees. Distributor shall obtain all necessary documents or licenses and shall comply with all applicable
laws, including, if required, registration of this Agreement. Distributor shall notify Manufacturer of all permits, approvals and registrations obtained by it and shall provide Manufacturer with copies of all material documents related thereto.
Distributor represents and warrants that it has obtained, or will obtain prior to commercial release, all required licenses and approvals of the Japanese Government in connection with this Agreement. With respect to obtaining the required approvals
(the Shonin) for distribution and sales of the AB5000 Console and the AB5000 Ventricle within the Territory, it is anticipated that such approvals will be received for the AB5000 Console and AB5000 Ventricle according to the milestone dates set
forth in Exhibit E, and that reimbursement approvals will be received within eighteen (18) months of the date that the Shonin is received. 
 With respect to obtaining the required licenses and approvals, including reimbursement approval for distribution and sales of the IMPELLA Console, the IMPELLA RECOVER LP 2.5 and the IMPELLA RECOVER LP 5.0 Pumps, Distributor is responsible
for the following steps: 
 i) Consult with the Japanese regulatory authorities prior to the start of the clinical trial; 
 ii) Design and establish the clinical trial in accordance with the regulatory path agreed upon among the regulatory authorities, Manufacturer, and
Distributor; 
 iii) Enroll patients in and manage the clinical trials beginning no later than three (3) months after submission;

 iv) Prepare the application and submit to PMDA within six (6) months of the final implantation in patients in the clinical trial;

  

 Page 8 

 v) Support the PMDA application through regulatory review and examination; 
 vi) Obtain PMDA approval no later than the milestone dates set forth in Exhibit E; and 
 vii) Upon obtaining PMDA approval, begin marketing and distribution of devices. 
 Distributor will cover all clinical and regulatory costs associated with any required clinical trials, regulatory submissions and receiving reimbursement
approval. Manufacturer will provide the IMPELLA RECOVER LP 2.5 and LP5.0 Pumps required for the clinical trials free of charge. Distributor will purchase the required IMPELLA Consoles at a per-console cost as set forth in Exhibit A. 
 Except for appropriately approved demonstration/test Products, Distributor shall not import or market the Products in Japan until the required licenses
and approvals of the Japanese Government have been granted for any particular product. Distributor shall submit to Manufacturer copies of all documents, material, information or data which were attached to the applications for approval, amendment to
approval, reexamination, report or reevaluation filed by Distributor with the Japanese Government in connection with the Products and other documents, material, information or data which are the basis for such documents, material, information or
data or which are relating to quality, efficiency or safety of the Products (the “Application Documents”). Distributor understands that Manufacturer is subject to regulation by agencies of the U.S. Government, including the U.S. Department
of Commerce, which prohibit export or diversion of certain technical products to certain countries. Distributor warrants that it will comply in all respects with the export and re-export restrictions set forth in the export license for every Product
shipped to Distributor. 
  

	 	h)	Limitation on Distributor and Distributor’s Rights to the Products. Distributor shall not have access to nor rights in the source codes of any software included in the
Products. Distributor shall have no right to copy, modify or re-manufacture any Product or part thereof. 

  

	 	7.	ADDITIONAL OBLIGATIONS OF MANUFACTURER 

  

	 	a)	Materials. Manufacturer shall promptly provide Distributor with marketing and technical information concerning the Products as well as reasonable quantities of brochures,
instructional material, advertising literature, reasonable sample allotment, and other Product data, with all such material printed in the Japanese language. 

  

	 	b)	Response to Inquiries. Manufacturer shall promptly respond to all inquiries from Distributor concerning matters pertaining to this Agreement. 

  

	 	c)	Testing. Manufacturer shall test all non-disposable Products before shipment to Distributor. 

  

	 	d)	Delivery Time. Manufacturer shall minimize delivery time as much as possible and use its reasonable efforts to fulfill delivery obligations as committed in acceptances.

  

 Page 9 

	 	e)	Territorial Inquiries. Manufacturer shall submit to Distributor any purchase inquiry originating from the Territory rather than answering the inquiry directly.

  

	 	f)	Quotations to Exporters. Manufacturer shall refrain from giving quotations to exporters for Products to be shipped to the Territory. 

  

	 	8.	TERM AND TERMINATION 

  

	 	a)	Term. This Agreement shall continue in force from the date of execution of this Agreement for a period of sixty (60) months (the “Initial Term”). After the
Initial Term, this Agreement shall automatically renew without notice for successive terms of one (1) year unless written notice not to renew the Agreement is given by either party to the other not less than thirty (30) days before the
expiry of the then current term. 

  

	 	b)	Termination for Cause. If Manufacturer defaults in the performance of any provision of this Agreement, then Distributor may give written notice to Manufacturer that if the
default is not cured within thirty (30) days, the Agreement will be terminated for cause. If Distributor defaults in the performance of any provision of this Agreement, other than a payment provision, then Manufacturer may give written notice
to Distributor that if the default is not cured within thirty (30) days, the Agreement will be terminated for cause. If Distributor defaults in the performance of a payment provision, then Manufacturer may give written notice to Distributor
that if the default is not cured within ten (10) days, the Agreement will be terminated for cause. If the non-defaulting party gives such notice and the default is not cured during the applicable period, then the Agreement shall automatically
terminate at the end of that period. 

  

	 	c)	Termination for Failure to Meet Regulatory Milestones. If Distributor fails to achieve the regulatory milestones outlined in the attached Exhibit E (hereinafter referred to
as “Regulatory Milestones”) then Manufacturer may choose to terminate this Agreement. Under such circumstances, Manufacturer agrees to provide Distributor with sixty (60) days’ advance written notice of its intention to terminate
this Agreement if said failure is not cured during that period of time. Notwithstanding the foregoing, Manufacturer may not terminate this Agreement for Distributor’s failure to achieve the Regulatory Milestones if such failure is due solely to
the failure of Manufacturer to provide necessary and reasonable information or take necessary and reasonable actions required in connection with the regulatory process which Distributor specifically and clearly requested from Manufacturer in writing
with sufficient notice to comply with such request for action or information and if such failure does in actual fact negatively impact the regulatory approval timeline. 

  

	 	d)	Termination for Insolvency. This Agreement shall terminate, without notice, (i) upon the institution by or against Distributor of insolvency, receivership or bankruptcy
proceedings, or any other proceedings for the settlement of Distributor’s debts, (ii) upon Distributor making an assignment for the benefit of creditors, or (iii) upon Distributor’s dissolution or ceasing to do business.

  

	 	e)	 Fulfillment of Orders Upon Termination. Upon termination of this Agreement for reasons other than Distributor’s breach or insolvency, Manufacturer shall
continue to fulfill, subject to 

  

 Page 10 

	 	 
the terms of Section 3 above, all orders accepted by Manufacturer prior to the date of termination. Manufacturer has no obligation to accept orders for
delivery or payment beyond the term of this Agreement 

  

	 	f)	Return of Materials. All trademarks, trade names, patents, copyrights, designs, drawings, trial and clinical data, formulas or other data, photographs, samples, literature,
and sales aids of every kind related to the Products and produced by the Manufacturer shall remain the property of Manufacturer. Within thirty (30) days after the termination of this Agreement, Distributor shall prepare all such items in its
possession for shipment, as Manufacturer may direct, at Manufacturer’s expense. Distributor shall not make, use, dispose of, or retain any copies of any confidential items or information which may have been entrusted to it. Effective upon the
termination of this Agreement, Distributor shall cease to use all trademarks, marks, and trade names of Manufacturer, provided however, that Distributor may use such trademarks, marks and trade names for a period of six (6) months in connection
with its disposition of its remaining inventory of the Product, if any. 

  

	 	g)	Limitation on Liability. In the event of termination by either party in accordance with any of the provisions of this Agreement, neither party shall be liable to the other,
because of such termination, for compensation, reimbursement or damages on account of the loss of prospective profits or anticipated sales or on account of expenditures, inventory, investments, leases or commitments in connection with the business
or goodwill of Manufacturer or Distributor. Termination shall not, however, relieve either party of obligations incurred prior to the termination. 

  

	 	h)	Government Approvals. Immediately upon termination of this Agreement for any reason, all government approvals, including, without limitation, the Shonin itself, and
Application Documents related thereto, shall be transferred and delivered to, and shall inure to the benefit of and for use by the Manufacturer, or to a Manufacturer’s designated assignee, to the extent that this is permissible under applicable
law, and Distributor agrees to assist Manufacturer in such transfer. If such transfer is not permitted under applicable law, Distributor agrees to cooperate with the cancellation of Distributor’s government approvals and the re-issuance thereof
to Manufacturer or Manufacturer’s designee. Distributor shall promptly return to Manufacturer all data and information relating to such Products including, but not limited to, the Application Documents and make no further use thereof.

 Upon termination of this Agreement for any reason, unless Distributor’s government approvals are legally transferred to
Manufacturer or its designee, or unless these approvals are in the process of being transferred to Manufacturer or its designee, Distributor shall immediately file a notification of cancellation of approval with the Japanese Government and send a
complete copy of the filing to Manufacturer. 
  

	 	i)	Survival of Certain Terms. The provisions of Sections 3(g), 3(j), 3(k), 5, 6(c), 6(h), 8, 9, 10, 11, 12 and 13 shall survive the termination of this Agreement for any reason.
All other rights and obligations of the parties shall cease upon termination of this Agreement. 

  

 Page 11 

	 	9.	LIMITATION ON LIABILITY 

 MANUFACTURER’S
LIABILITY ARISING OUT OF THIS AGREEMENT AND/OR SALE OF THE PRODUCTS SHALL BE LIMITED TO THE AMOUNT PAID BY THE CUSTOMER FOR THE PRODUCTS. IN NO EVENT SHALL MANUFACTURER BE LIABLE FOR COSTS OF PROCUREMENT OF SUBSTITUTE GOODS. IN NO EVENT SHALL
MANUFACTURER BE LIABLE TO DISTRIBUTOR FOR ANY SPECIAL, CONSEQUENTIAL, INCIDENTAL, OR INDIRECT DAMAGES, HOWEVER CAUSED, ON ANY THEORY OF LIABILITY. 
  

	 	10.	PROPERTY RIGHTS AND CONFIDENTIALITY 

  

	 	a)	Property Rights. Distributor agrees that Manufacturer owns all right, title and interest in the product lines that include the Products and all of Manufacturer’s
patents, trademarks, trade names, inventions, copyrights, know-how, and trade secrets relating to the design, manufacture, operation or service of the Products. The use by Distributor of any of these property rights is authorized only for the
purposes herein set forth, and upon termination of this Agreement, for any reason, such authorization shall cease, except as provided in Subsection 8(f) above. 

  

	 	b)	Sale Conveys No Right to Manufacture or Copy. The Products are offered for sale and are sold by Manufacturer subject in every case to the condition that such sales do not
convey any license, expressly or by implication, to manufacture, duplicate or otherwise copy or reproduce any of the Products. Distributor shall take appropriate steps with its customers, as Manufacturer may request, to inform them of and assure
compliance with the restrictions contained in this Subsection 10(b). 

  

	 	c)	Confidentiality. Distributor acknowledges that by reason of its relationship to Manufacturer hereunder, it has access to certain information and materials concerning
Manufacturer’s business, plans, customers, technology, and products that are confidential and of substantial value to Manufacturer, which value would be impaired if such information were disclosed to third parties. Distributor agrees that it
will not use in any way for its own account or the account of any third party, nor disclose to any third party, any such confidential information revealed to it by Manufacturer, except as contemplated by this Agreement. Distributor shall take every
reasonable precaution to protect the confidentiality of such information. Upon request by Distributor, Manufacturer shall advise whether or not it considers any particular information or materials to be confidential and Distributor shall not publish
any technical description of the Products beyond the description published by Manufacturer (except to translate that description into appropriate languages for the Territory). In the event of termination of this Agreement, there shall be no use or
disclosure by Distributor of any confidential information of Manufacturer, and Distributor shall not manufacture, or have manufactured any devices, components or assemblies utilizing any of Manufacturer’s confidential information.

  

 Page 12 

	 	11.	TRADEMARKS AND TRADE NAMES 

  

	 	a)	Use. During the term of this Agreement, Distributor shall have the right to indicate to the public that it is an authorized Distributor of the Products and to advertise
(within the Territory) such Products under the trademarks, marks, and trade names that Manufacturer may adopt from time to time. Distributor may not alter or remove any of Manufacturer’s Trademarks applied to the Products at the factory. Except
as set forth in this Section 11, nothing contained in this Agreement shall grant to Distributor any right, title or interest in Manufacturer’s Trademarks. At no time during or after the term of this Agreement shall Distributor challenge or
assist others to challenge Manufacturer’s Trademarks or the registration thereof, or attempt to register any trademarks, marks or trade names confusingly similar to those of Manufacturer. 

  

	 	b)	Approval of Representations. All representations of Manufacturer’s Trademarks that Distributor intends to use shall first be submitted to Manufacturer for approval of
design, color, and other details or shall be exact copies of those used by Manufacturer. If any of Manufacturer’s Trademarks are to be used in conjunction with another trademark on or in relation to the Products, then Manufacturer’s mark
shall be presented equally legibly, equally prominently, and of greater size than the other, but nevertheless separated from the other, so that each appears to be a mark in its own right, distinct from the other mark. 

  

	 	12.	PATENT, COPYRIGHT, AND TRADEMARK INDEMNITY 

  

	 	a)	Indemnification. Distributor agrees that Manufacturer has the right to defend, or at its option to settle, and Manufacturer agrees, at its own expense, to defend or at its
option to settle, any claim, suit or proceeding brought against Distributor or its customer on the issue of infringement of any patent, copyright or trademark by the Products sold hereunder or the use thereof, subject to the limitations hereinafter
set forth. Manufacturer shall have sole control of any such action or settlement negotiations, and Manufacturer agrees to pay, subject to the limitations hereinafter set forth, any final judgment entered against Distributor or its customer on such
issue in any such suit or proceeding defended by Manufacturer. Distributor agrees that Manufacturer at its sole option shall be relieved of the foregoing obligations unless Distributor or its customer notifies Manufacturer promptly in writing of
such claim, suit or proceeding and gives Manufacturer authority to proceed as contemplated herein, and, at Manufacturer’s expense, gives Manufacturer proper and full information and assistance to settle and/or defend any such claim, suit or
proceeding. If the Products, or any part thereof, are, or in the opinion of Manufacturer may become, the subject of any claim, suit or proceeding for infringement of any patent, copyright or trademark, or if it is judicially determined that the
Products, or any part thereof, infringe any patent, copyright or trademark, or if the sale or use of the Products, or any part thereof, is, as a result, enjoined, then Manufacturer may, at its option and expense either: (i) procure for
Distributor and its customers the right under such patent, copyright or trademark to sell or use, as appropriate, the Products or such part thereof; or (ii) replace the Products, or part thereof, with other suitable Products or parts; or
(iii) suitably modify the Products, or part thereof; or (iv) if the use of the Products, or part thereof, is prevented by injunction, remove the Products, and refund the aggregate payments paid therefore by Distributor, less a reasonable
sum for use and damage. Manufacturer shall not be liable for any costs or expenses incurred without its prior written authorization. 

  

 Page 13 

	 	b)	Limitation. Notwithstanding the provisions of Subsection 12(a) above, Manufacturer assumes no liability for (i) infringements covering completed equipment or any
assembly, circuit, combination, method or process in which any of the Products may be used, but not covering the Products when used alone; (ii) trademark infringements involving any marking or branding not applied by Manufacturer or involving
any marking or branding applied at the request of Distributor; or (iii) infringements involving the modification or servicing of the Products, or any part thereof, unless such modification or servicing was done by Manufacturer.

  

	 	c)	Entire Liability. The foregoing provisions of this Section 12 state the entire liability and obligations of Manufacturer and the exclusive remedy of Distributor and its
customer, with respect to any alleged infringement of patents, copyrights, trademarks or other intellectual property rights by the Products or any part thereof. 

  

	 	13.	GENERAL PROVISIONS 

  

	 	a)	Governing Law and Jurisdiction. This Agreement shall be governed, construed and enforced under the internal laws of the Commonwealth of Massachusetts, U.S.A. If any provision
of this Agreement is held to be unenforceable, the remaining portion of the Agreement shall remain in full force and effect. Manufacturer and Distributor agree to consider arbitration as a means of resolving any disputes hereunder which can not be
otherwise resolved. Without limitation to the foregoing, it is understood that the United Nations conventions shall not govern this Agreement. 

  

	 	b)	Entire Agreement. This Agreement sets forth the entire agreement and understanding of the parties relating to the subject matter herein and replaces and supersedes all prior
discussions, letters and agreements between Manufacturer and Distributor. No modification nor amendment to this Agreement, nor any waiver of any rights under this Agreement, shall be effective unless in writing signed by a duly authorized
representative of the party to be bound thereby. 

  

	 	c)	Notices. Any notice required or permitted by this Agreement shall be in writing and shall be sent by prepaid registered or certified mail, return receipt requested, addressed
to the other party at the address shown at the beginning of this Agreement, or at such other address for which such party gives notice hereunder. Such notice shall be deemed to have been given three (3) days after deposit in the mail.

  

	 	d)	Force Majeure. Non-performance of either party shall be excused to the extent that performance is rendered impossible by strike, insurrection, flood, governmental acts or
orders or restrictions, failure of suppliers, or any other reason where failure to perform is beyond the reasonable control of, and is not caused by, the negligence of the non-performing party. 

  

 Page 14 

	 	e)	Parties Include Affiliates. For purposes of this Agreement, Manufacturer shall include ABIOMED, Inc., and all majority-owned subsidiaries, including Impella CardioSystems,
Gmbh, and any other controlled companies of ABIOMED, Inc. 

  

	 	f)	Nonassignability and Binding Effect. A mutually agreed consideration for Manufacturer’s entering into this Agreement is the reputation, business standing, and goodwill
already honored and enjoyed by Distributor under its present ownership, and, accordingly, Distributor agrees that its rights and obligations under this Agreement may not be transferred or assigned directly or indirectly without the prior written
consent of Manufacturer. Subject to the foregoing sentence, this Agreement shall be binding upon and inure to the benefit of the parties hereto and their successors and assigns. 

  

	 	g)	Legal Expenses. The prevailing party in any legal action or arbitration brought by one party against the other and arising out of this Agreement shall be entitled, in
addition to any other rights and remedies it may have, to reimbursement for its expenses, including court costs and reasonable attorney’s fees. 

  

	 	h)	Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original and all of which together shall constitute one instrument.

  

					
	ABIOMED, Inc.	 		 	Medix Japan, Inc.
			
	/s/ Michael R. Minogue	 		 	/s/ Yasuhiro Matsuoka
	Name: Michael R. Minogue	 		 	Name: Yasuhiro Matsuoka
	Title: President	 		 	Title: President
	Date: 6th Nov 2006	 		 	Date: November 4, 2006

  

 Page 15Form of Restricted Stock Award Agreement

 Exhibit 4.1 
 KILROY REALTY 
 2006 INCENTIVE AWARD PLAN 
 RESTRICTED STOCK AWARD GRANT NOTICE AND 
 RESTRICTED STOCK AWARD AGREEMENT 
 Kilroy Realty Corporation, a Maryland corporation (the
“Company”), pursuant to the Kilroy Realty 2006 Incentive Award Plan (the “Plan”), hereby grants to the individual listed below (“Participant”), the number of shares of the
Company’s common stock, par value $.01 per share, set forth below (the “Shares”). This Restricted Stock Award is subject to all of the terms and conditions as set forth herein and in the Restricted Stock Award Agreement
attached hereto as Exhibit A (the “Restricted Stock Agreement”) (including without limitation the Restrictions on the Shares set forth in the Restricted Stock Agreement) and the Plan, each of which are incorporated
herein by reference. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Grant Notice and the Restricted Stock Agreement. 
  

			
	Participant:	  	__________________________________________________________
		
	Grant Date:	  	__________________________________________________________
		
	Total Number of Shares of Restricted Stock:	  	_____________________________________________________shares
		
	Purchase Price:	  	$_________________________________________________________
		
	Vesting Schedule:	  	

 By his or her signature below, Participant agrees to be bound by the terms and conditions of the
Plan, the Restricted Stock Agreement and this Grant Notice. Participant has reviewed the Restricted Stock Agreement, the Plan and this Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this
Grant Notice and fully understands all provisions of this Grant Notice, the Restricted Stock Agreement and the Plan. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any
questions arising under the Plan, this Grant Notice or the Restricted Stock Agreement. If Participant is married, his or her spouse has signed the Consent of Spouse attached to this Grant Notice as Exhibit B. 
  

									
	KILROY REALTY CORPORATION:	 		 	PARTICIPANT:
					
	By:	 	  	 		 	By:	 	  
	Print Name:	 	  	 		 	Print Name:	 	  
	Title:	 	  	 		 		 	
		 		 		 	Address:	 	  
		 		 		 		 	  

  

			
	KILROY REALTY, L.P.:
		
	By:	 	  
	Print Name:	 	  
	Title:	 	  

 EXHIBIT A 
 TO RESTRICTED STOCK AWARD GRANT NOTICE 
 KILROY REALTY RESTRICTED STOCK AWARD AGREEMENT

 This Restricted Stock Award Agreement (the “Agreement”), dated as of __________, 200__, is made and entered
into by and between Kilroy Realty Corporation, a Maryland corporation (the “Company”), Kilroy Realty, L.P., a Maryland limited partnership (the “Employer”), and ____________ (the
“Participant”). Pursuant to the Restricted Stock Award Grant Notice (the “Grant Notice”) to which this Agreement is attached, the Company has granted to Participant the right to purchase the number of
shares of Restricted Stock under the Kilroy Realty 2006 Incentive Award Plan (as amended from time to time, the “Plan”) as set forth in the Grant Notice. 
 ARTICLE I. 
 GENERAL 
 1.1 Definitions. All capitalized terms used in this Agreement without definition shall have the meanings ascribed in the Plan and the Grant
Notice. 
 1.2 Incorporation of Terms of Plan. The Award is subject to the terms and conditions of the Plan which are incorporated
herein by reference. In the event of any inconsistency between the Plan and this Agreement, the terms of the Plan shall control. 
 ARTICLE
II. 
 AWARD OF RESTRICTED STOCK 
 2.1 Award of Restricted Stock. 
 (a) Award. In consideration of the
Participant’s agreement to remain in the service or employ of the Company, the Employer, the TRS or any Subsidiary (as applicable), and for other good and valuable consideration, the Company issues to the Participant the Award described in this
Agreement (the “Award”). The number of shares of Restricted Stock (the “Shares”) subject to the Award is set forth in the Grant Notice. 
 (b) Purchase Price; Book Entry Form. The purchase price of the Shares is set forth on the Grant Notice. At the sole discretion of
the Committee, the Shares will be issued in either (i) uncertificated form, with the Shares recorded in the name of the Participant in the books and records of the Company’s transfer agent with appropriate notations to the extent that the
Shares remain subject to the Restrictions (as defined below); or (ii) certificate form pursuant to the terms of Sections 2.1(c) and (d). 
 (c) Legend. Certificates representing Shares issued pursuant to this Agreement shall, until all restrictions on transfer imposed pursuant to this Agreement lapse or shall have been removed and new certificates
are issued, bear the following legend (or such other legend as shall be determined by the Committee): 
 “THE SECURITIES REPRESENTED BY
THIS CERTIFICATE ARE SUBJECT TO CERTAIN VESTING REQUIREMENTS AND MAY BE SUBJECT TO FORFEITURE UNDER THE TERMS OF THAT CERTAIN RESTRICTED STOCK AWARD 

  

 A-1 

 
AGREEMENT, DATED ____________ __, 200_, BY AND BETWEEN KILROY REALTY CORPORATION, KILROY REALTY, L.P. AND THE REGISTERED OWNER OF SUCH SHARES, AND SUCH
SHARES MAY NOT BE, DIRECTLY OR INDIRECTLY, OFFERED, TRANSFERRED, SOLD, ASSIGNED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF UNDER ANY CIRCUMSTANCES, EXCEPT PURSUANT TO THE PROVISIONS OF SUCH AGREEMENT.” 
 (d) Escrow. The Secretary of the Company or such other escrow holder as the Committee may appoint may retain physical custody of
the certificates representing the Shares until all of the restrictions on transfer imposed pursuant to this Agreement lapse or shall have been removed. In such event the Participant shall not retain physical custody of any certificates representing
unvested Shares issued to the Participant. 
 2.2 Restrictions. 
 (a) Repurchase of Shares Subject to Restrictions. In the event that the Participant ceases to be an Employee, member of the Board,
Consultant or TRS Director for any reason, the Company or the Employer shall have the right to repurchase from the Participant any or all Shares then subject to the Restrictions at a cash price per Share equal to the price paid by the Participant
for such Shares. For purposes of this Agreement, “Restrictions” shall mean the restrictions on sale or other transfer set forth in Section 3.1 and the exposure to repurchase set forth in this Section 2.2(a).

 (b) Vesting and Lapse of Restrictions. Subject to Sections 2.2(a) and 3.2, the Award shall vest and the Restrictions
shall lapse in accordance with the vesting schedule set forth on the Grant Notice. 
 (c) Tax Withholding; Conditions to
Issuance of Certificates. Notwithstanding any other provision of this Agreement (including without limitation Section 2.1(b)): 
 (i) No Shares shall be recorded in the name of the Participant in the books and records of the Company’s transfer agent and no new certificate shall be delivered to the Participant or his legal representative
unless and until the Participant or his legal representative shall have paid to the Company or the Employer the full amount of all federal and state withholding or other taxes applicable to the taxable income of Participant resulting from the grant
of Shares or the lapse or removal of the Restrictions. 
 (ii) The Company shall not be required to record any Shares in the
name of the Participant in the books and records of the Company’s transfer agent, and neither the Company nor the Employer shall be required to issue or deliver any certificate or certificates for any Shares prior to the fulfillment of all of
the following conditions: (A) the admission of the Shares to listing on all stock exchanges on which the Company’s common stock is then listed, (B) the completion of any registration or other qualification of the Shares under any
state or federal law or under rulings or regulations of the Securities and Exchange Commission or other governmental regulatory body, which the Committee shall, in its sole and absolute discretion, deem necessary and advisable, (C) the
obtaining of any approval or other clearance from any state or federal governmental agency that the Committee shall, in its absolute discretion, determine to be necessary or advisable and (D) the lapse of any such reasonable period of time
following the date the Restrictions lapse as the Committee may from time to time establish for reasons of administrative convenience. 
  

 A-2 

 ARTICLE III. 
 OTHER PROVISIONS 
 3.1 Restricted Stock Not Transferable. No Shares that are subject to the
Restrictions or any interest or right therein or part thereof shall be liable for the debts, contracts or engagements of the Participant or his successors in interest or shall be subject to disposition by transfer, alienation, anticipation, pledge,
encumbrance, assignment or any other means whether such disposition be voluntary or involuntary or by operation of law by judgment, levy, attachment, garnishment or any other legal or equitable proceedings (including bankruptcy), and any attempted
disposition thereof shall be null and void and of no effect; provided, however, that this Section 3.1 notwithstanding, with the consent of the Committee, the Shares may be transferred to certain persons or entities related to
Participant, including but not limited to members of Participant’s family, charitable institutions or trusts or other entities whose beneficiaries or beneficial owners are members of Participant’s family and/or charitable institutions, or
to such other persons or entities as may be expressly approved by the Committee, pursuant to any such conditions and procedures the Committee may require. Notwithstanding the foregoing, in no event shall the Award be transferable by the Participant
to a third party (other than the Company, the Partnership, the TRS or any Subsidiary) for consideration. 
 3.2 Ownership Limit and REIT
Status. Notwithstanding anything contained herein, the Award shall not vest and the Restrictions shall not lapse: 
 (a)
to the extent that such vesting or lapsing could cause the Participant to be in violation of the Ownership Limit (as defined in the Company’s Articles of Incorporation, as amended from time to time) or Subparagraph E(2) of Article IV (or any
successor provision thereto) of the Company’s Articles of Incorporation, as amended from time to time; or 
 (b) if, in
the discretion of the Committee, such vesting or lapsing could impair the Company’s status as a REIT. 
 3.3 Rights as
Stockholder. Except as otherwise provided herein, upon the Grant Date the Participant shall have all the rights of a stockholder with respect to the Shares, subject to the Restrictions herein, including the right to vote the Shares and the right
to receive any cash or stock dividends paid to or made with respect to the Shares. 
 3.4 Not a Contract of Employment. Nothing in
this Agreement or in the Plan shall confer upon the Participant any right to continue to serve as an employee or other service provider of the Company, the Partnership, the TRS or any Subsidiary. 
 3.5 Governing Law. The laws of the State of Maryland shall govern the interpretation, validity, administration, enforcement and performance of the
terms of this Agreement regardless of the law that might be applied under principles of conflicts of laws. 
 3.6 Conformity to Securities
Laws. The Participant acknowledges that the Plan and this Agreement are intended to conform to the extent necessary with all provisions of the Securities Act of 1933, as amended, and the Exchange Act, and any and all regulations and rules
promulgated thereunder by the Securities and Exchange Commission, including without limitation Rule 16b-3 under the Exchange Act. Notwithstanding anything herein to the contrary, the Plan shall be administered, and the Award is granted, only in such
a manner as to conform to such laws, rules and regulations. To the extent permitted by applicable law, the Plan and this Agreement shall be deemed amended to the extent necessary to conform to such laws, rules and regulations. 
  

 A-3 

 3.7 Amendment, Suspension and Termination. To the extent permitted by the Plan, this Agreement may
be wholly or partially amended or otherwise modified, suspended or terminated at any time or from time to time by the Committee or the Board, provided, that, except as may otherwise be provided by the Plan, no amendment, modification,
suspension or termination of this Agreement shall adversely effect the Award in any material way without the prior written consent of the Participant. 
 3.8 Notices. Notices required or permitted hereunder shall be given in writing and shall be deemed effectively given upon personal delivery or upon deposit in the United States mail by certified mail, with
postage and fees prepaid, addressed to the Participant to his address shown in the Company records, and to the Company or the Employer at their principal executive offices. 
 3.9 Successors and Assigns. The Company and the Employer may assign any of their rights under this Agreement to single or multiple assignees, and
this Agreement shall inure to the benefit of the successors and assigns of the Company or the Employer. Subject to the restrictions on transfer herein set forth, this Agreement shall be binding upon Participant and his or her heirs, executors,
administrators, successors and assigns. 
 [SIGNATURE PAGE FOLLOWS] 
  

 A-4 

 IN WITNESS WHEREOF, this Agreement has been executed and delivered by the parties hereto. 
  

			
	KILROY REALTY CORPORATION,
	a Maryland corporation
		
	By:	 	  
		 	    [Name]
		 	    [Title]

  

			
	KILROY REALTY, L.P.,
	a Maryland limited partnership
		
	By:	 	Kilroy Realty Corporation, a Maryland corporation
	Its:	 	General Partner
		
	By:	 	  
		 	    [Name]
		 	    [Title]

  

	
	PARTICIPANT
	
	   
	[Name]

  

 A-5 

 EXHIBIT B 
 TO RESTRICTED STOCK AWARD GRANT NOTICE  
 CONSENT OF SPOUSE 
 I, ____________________, spouse of _______________, have read and approve the foregoing Agreement. In consideration of issuing to my spouse the shares of
the common stock of Kilroy Realty Corporation set forth in the Agreement, I hereby appoint my spouse as my attorney-in-fact in respect to the exercise of any rights under the Agreement and agree to be bound by the provisions of the Agreement insofar
as I may have any rights in said Agreement or any shares of the common stock of Kilroy Realty Corporation issued pursuant thereto under the community property laws or similar laws relating to marital property in effect in the state of our residence
as of the date of the signing of the foregoing Agreement. 
  

					
	Dated:                     ,
            	 		 	  
		 		 	Signature of Spouse

  

 B-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00116-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00116-of-00352.parquet"}]]